Teva Comments On Sandoz Implications Amid Strategic Review

Israeli Firm Has Ruled Itself Out Of Merging With Novartis Unit

 
• By Dean Rudge
  
Teva has offered its opinion on the potential Sandoz deal • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Business

More from Generics Bulletin